1#@!#!123s

https 1#@!#!123s
: / home2 / affluencebiotech / mail / new /
Filename : 1736271897.M572682P20721.server55.dnsserverboot.com,S=5019,W=5125
back
Envelope-to: affluencebiotech@server55.dnsserverboot.com
Delivery-date: Tue, 07 Jan 2025 23:14:57 +0530
Auto-Submitted: auto-replied
From: Mail Delivery System <Mailer-Daemon@server55.dnsserverboot.com>
To: affluencebiotech@server55.dnsserverboot.com
Content-Type: multipart/report; report-type=delivery-status; boundary=1736271897-eximdsn-52899305
MIME-Version: 1.0
Subject: Mail delivery failed: returning message to sender
Message-Id: <E1tVDdR-0006iE-HT@server55.dnsserverboot.com>
Date: Tue, 07 Jan 2025 23:14:57 +0530

--1736271897-eximdsn-52899305
Content-type: text/plain; charset=us-ascii

This message was created automatically by mail delivery software.

A message that you sent could not be delivered to one or more of its
recipients. This is a permanent error. The following address(es) failed:

  kristjan.kusar@gmail.com
    host gmail-smtp-in.l.google.com [142.251.173.27]
    SMTP error from remote mail server after end of data:
    550-5.7.26 Your email has been blocked because the sender is unauthenticated.
    550-5.7.26 Gmail requires all senders to authenticate with either SPF or DKIM.
    550-5.7.26
    550-5.7.26  Authentication results:
    550-5.7.26  DKIM = did not pass
    550-5.7.26  SPF [server55.dnsserverboot.com] with ip:
    [51.210.156.4] = did not
    550-5.7.26 pass
    550-5.7.26
    550-5.7.26  For instructions on setting up authentication, go to
    550 5.7.26  https://support.google.com/mail/answer/81126#authentication 5b1f17b1804b1-436631ba96csi260313825e9.121 - gsmtp

--1736271897-eximdsn-52899305
Content-type: message/delivery-status

Reporting-MTA: dns; server55.dnsserverboot.com

Action: failed
Final-Recipient: rfc822;kristjan.kusar@gmail.com
Status: 5.0.0
Remote-MTA: dns; gmail-smtp-in.l.google.com
Diagnostic-Code: smtp; 550-5.7.26 Your email has been blocked because the sender is unauthenticated.
 550-5.7.26 Gmail requires all senders to authenticate with either SPF or DKIM.
 550-5.7.26
 550-5.7.26  Authentication results:
 550-5.7.26  DKIM = did not pass
 550-5.7.26  SPF [server55.dnsserverboot.com] with ip: [51.210.156.4] = did not
 550-5.7.26 pass
 550-5.7.26
 550-5.7.26  For instructions on setting up authentication, go to
 550 5.7.26  https://support.google.com/mail/answer/81126#authentication 5b1f17b1804b1-436631ba96csi260313825e9.121 - gsmtp

--1736271897-eximdsn-52899305
Content-type: message/rfc822

Return-path: <affluencebiotech@server55.dnsserverboot.com>
Received: from affluencebiotech by server55.dnsserverboot.com with local (Exim 4.89_1)
	(envelope-from <affluencebiotech@server55.dnsserverboot.com>)
	id 1tVDdP-0006hY-2f
	for kristjan.kusar@gmail.com; Tue, 07 Jan 2025 23:14:57 +0530
To: kristjan.kusar@gmail.com
Subject: 
X-PHP-Script: atto-trade.com/mailcontact.php for 149.34.252.12, 172.71.144.162, 149.34.252.12
 X-PHP-Originating-Script: 4213:mailcontact.php
From:Contact-Enquiry@server55.dnsserverboot.com
Message-Id: <E1tVDdP-0006hY-2f@server55.dnsserverboot.com>
Date: Tue, 07 Jan 2025 23:14:55 +0530
X-OutGoing-Spam-Status: No, score=2.3

Mathew

 Email: fannie.trainor@gmail.com

  Message: Hello

I hope this message finds you well. My name is Mathew, and I am a Research Assistant in the Research and Development Department one of the leading biopharmaceutical company based in London, England. I am reaching out to explore a potential partnership opportunity. 

We are currently seeking a reliable business representative in your region to assist us in sourcing essential raw materials used in the production of high-quality antiviral vaccines, cancer treatments, and other life-saving pharmaceutical products. While this may be outside of your primary area of expertise, it offers a unique opportunity to diversify your business interests and generate additional income.

Our company has been actively searching for a reputable supplier but has yet to establish a direct source. 

However, I have identified a local supplier who offers the necessary materials at a significantly lower cost compared to our previous purchases. This could present a mutually beneficial opportunity for both parties.

If you are interested in learning more about the profit structure and the specifics of this potential collaboration, please feel free to reach out. 

I would be happy to provide additional details at your convenience.

Thank you for considering this partnership, and I look forward to your response.

Mathew Lundgren
Research & Dev Dept
Email: mathew@mathewlundgren.com

--1736271897-eximdsn-52899305--